These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 20555146

  • 1. Brain perfusion correlates of visuoperceptual deficits in mild cognitive impairment and mild Alzheimer's disease.
    Alegret M, Vinyes-Junqué G, Boada M, Martínez-Lage P, Cuberas G, Espinosa A, Roca I, Hernández I, Valero S, Rosende-Roca M, Mauleón A, Becker And JT, Tárraga L.
    J Alzheimers Dis; 2010; 21(2):557-67. PubMed ID: 20555146
    [Abstract] [Full Text] [Related]

  • 2. A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease.
    Alegret M, Cuberas-Borrós G, Vinyes-Junqué G, Espinosa A, Valero S, Hernández I, Roca I, Ruíz A, Rosende-Roca M, Mauleón A, Becker JT, Castell-Conesa J, Tárraga L, Boada M.
    J Alzheimers Dis; 2012; 30(1):109-20. PubMed ID: 22406443
    [Abstract] [Full Text] [Related]

  • 3. Detection of visuoperceptual deficits in preclinical and mild Alzheimer's disease.
    Alegret M, Boada-Rovira M, Vinyes-Junqué G, Valero S, Espinosa A, Hernández I, Modinos G, Rosende-Roca M, Mauleón A, Becker JT, Tárraga L.
    J Clin Exp Neuropsychol; 2009 Oct; 31(7):860-7. PubMed ID: 19142775
    [Abstract] [Full Text] [Related]

  • 4. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.
    Nobili F, Brugnolo A, Calvini P, Copello F, De Leo C, Girtler N, Morbelli S, Piccardo A, Vitali P, Rodriguez G.
    Clin Neurophysiol; 2005 Feb; 116(2):364-75. PubMed ID: 15661114
    [Abstract] [Full Text] [Related]

  • 5. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT.
    Hirao K, Ohnishi T, Hirata Y, Yamashita F, Mori T, Moriguchi Y, Matsuda H, Nemoto K, Imabayashi E, Yamada M, Iwamoto T, Arima K, Asada T.
    Neuroimage; 2005 Dec; 28(4):1014-21. PubMed ID: 16129627
    [Abstract] [Full Text] [Related]

  • 6. Brain perfusion SPECT in patients with mild cognitive impairment and Alzheimer's disease: comparison of a semiquantitative and a visual evaluation.
    Staffen W, Schönauer U, Zauner H, Spindler I, Mair A, Iglseder B, Bernroider G, Ladurner G.
    J Neural Transm (Vienna); 2006 Feb; 113(2):195-203. PubMed ID: 15959843
    [Abstract] [Full Text] [Related]

  • 7. Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment.
    Habert MO, Horn JF, Sarazin M, Lotterie JA, Puel M, Onen F, Zanca M, Portet F, Touchon J, Verny M, Mahieux F, Giron A, Fertil B, Dubois B.
    Neurobiol Aging; 2011 Jan; 32(1):15-23. PubMed ID: 19250707
    [Abstract] [Full Text] [Related]

  • 8. HMPAO-SPECT Can Discriminate between Patients with Subjective Cognitive Complaints with and without Cognitive Deficits and those with Mild Cognitive Impairment.
    Rossini F, Zauner H, Bergmann J, Kronbichler M, Spindler I, Golaszewski S, Trinka E, Staffen W.
    Curr Alzheimer Res; 2019 Jan; 16(9):843-851. PubMed ID: 31453786
    [Abstract] [Full Text] [Related]

  • 9. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
    Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC, Jagust WJ, Gorno-Tempini ML, Schuff N.
    Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
    [Abstract] [Full Text] [Related]

  • 10. Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study.
    Nobili F, Frisoni GB, Portet F, Verhey F, Rodriguez G, Caroli A, Touchon J, Calvini P, Morbelli S, De Carli F, Guerra UP, Van de Pol LA, Visser PJ.
    J Neurol; 2008 Sep; 255(9):1344-53. PubMed ID: 18958573
    [Abstract] [Full Text] [Related]

  • 11. Neural basis of visual perception and reasoning ability in Alzheimer's disease: correlation between Raven's Colored Progressive Matrices test and 123 I-IMP SPECT imaging results.
    Yoshida T, Mori T, Shimizu H, Yoshino Y, Sonobe N, Matsumoto T, Kikuchi K, Miyagawa M, Iga J, Mochizuki T, Ueno SI.
    Int J Geriatr Psychiatry; 2017 Apr; 32(4):407-413. PubMed ID: 27094214
    [Abstract] [Full Text] [Related]

  • 12. Preclinical evidence of Alzheimer changes in progressive mild cognitive impairment: a qualitative and quantitative SPECT study.
    Ishiwata A, Sakayori O, Minoshima S, Mizumura S, Kitamura S, Katayama Y.
    Acta Neurol Scand; 2006 Aug; 114(2):91-6. PubMed ID: 16867030
    [Abstract] [Full Text] [Related]

  • 13. [Prediction of progression in patients with mild cognitive impairment using IMP-SPECT].
    Okamura N, Shinkawa M, Arai H, Matsui T, Nakajo K, Maruyama M, Hu XS, Sasaki H.
    Nihon Ronen Igakkai Zasshi; 2000 Dec; 37(12):974-8. PubMed ID: 11201187
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
    Lin KJ, Hsiao IT, Hsu JL, Huang CC, Huang KL, Hsieh CJ, Wey SP, Yen TC.
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.